logo
Plus   Neg
Share
Email

WH Smith 11-week Total Group Sales Up 15%; CEO Stephen Clarke To Step Down

WH Smith Plc. (SMWH.L) reported that its total Group sales for the 11 week period from 1 March to 18 May 2019 were up 15% or up 4% excluding InMotion, with like-for-like sales up 1%. The company remains confident in the outcome for the full year. WH Smith also said that its Group Chief Executive Stephen Clarke has decided to step down from his role on 31 October 2019.

WH Smith said that it has appointed Carl Cowling to succeed Stephen Clarke as Group Chief Executive, effect from 1 November 2019. Carl Cowling was appointed as a member of the Board on 26 February 2019 and is currently Managing Director of the WH Smith High Street business.

In Travel business total sales were up 26% or up 7% excluding InMotion and like-for-like sales were up 3%.

In High Street business, total sales were down 1% and like-for-like sales were also down 1%.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Just Egg, a plant-based egg alternative, will be available in 2,100 stores owned by grocery chain Kroger Co. later this month. The product launch comes as plant-based meat and egg alternatives gain traction in the country. Just Egg, a product of California-based food technology company Just Inc., will be available at Kroger-owned stores, including Kroger, Fred Meyer and Ralphs. Boeing has delivered the first 787-10 Dreamliner to Vietnam Airlines, the flag carrier of Vietnam, as part of the eight 787-10 Dreamliner airplanes to be delivered on lease through Air Lease. Vietnam Airlines said the 787-10 Dreamliner, claimed by Boeing to be the most fuel-efficient twin-aisle airplane in the industry, will help it raise the customer experience on the Hanoi to Ho Chi Minh route. The U.S. Food and Drug Administration or FDA announced on its website that pharma major Pfizer, Inc. issued recall of two lots of tablets meant to treat acute migraine in adults for concerns over bacteria infection. The pharma company is recalling two lots of Relpax (eletriptan hydrobromide) 40 mg tablets for potential presence of Genus Pseudomonas and Burkholderia bacteria.
Follow RTT